Dr Reddys Laboratories (RDY) Current Deferred Tax Assets (2009)
Dr Reddys Laboratories (RDY) posted quarterly Current Deferred Tax Assets of $22.0 million for Q4 2009, down 4.35% quarter-over-quarter from $23.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Current Deferred Tax Assets (2009) Analysis & Trends
Dr Reddys Laboratories' Current Deferred Tax Assets history runs 1 years deep, the most recent figure standing at $22.0 million for Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 22.00 Mn |
| Dec 31, 2009 | 22.00 Mn |
| Sep 30, 2009 | 23.00 Mn |
| Sep 30, 2009 | 23.00 Mn |
| Jun 30, 2009 | 32.00 Mn |
| Jun 30, 2009 | 32.00 Mn |